Global platform to inform investments for health R&D.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  The Lancet

• Publication date

  2016-03-19

• Fields of study

  Medicine, Business, Economics

• Identifiers
  DOI 10.1016/S0140-6736(16)00705-4PMID 27025327
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• International cooperation to improve access to and sustain effectiveness of antimicrobials.

  2016cited by this paper
• Infection Control Best Practices in Clinical Research in Resource-Limited Settings

  2014cited by this paper
• Mapping of available health research and development data: what's there, what's missing, and what role is there for a global observatory?

  2013cited by this paper
• [Tuberculosis among health care workers].

  2010cited by this paper

• P2O5 Mediated an Efficient Synthesis and Biological Evaluation of Heterocyclic-fused Pyrimidine Derivatives as an Antitubercular Agent

  2018cites this paper
• Glycerol Mediated Synthesis, Biological Evaluation, and Molecular Docking Study of 4‐(1 H ‐pyrazol‐4‐yl)‐polyhydroquinolines as Potent Antitubercular Agents

  2018cites this paper
• Global funding trends for malaria research in sub-Saharan Africa: a systematic analysis

  2017cites this paper
• Antimicrobial Resistance in a One Health and One World Perspective – Mechanisms and Solutions

  2017cites this paper
• Genetic diversity of multidrug‐resistant Mycobacterium tuberculosis strains isolated from tuberculosis patients in Iran using MIRU‐VNTR technique

  2017cites this paper
• Are we investing wisely? A systematic analysis of nationally funded antimicrobial resistance projects in Republic of Korea, 2003-2013.

  2016cites this paper
• Building Sustainable Local Capacity for Global Health Research in West Africa.

  2016cites this paper